(Q37830358)

24 August 2017

1 reference

title

Why is the coexistence of gastric cancer and duodenal ulcer rare? Examination of factors related to both gastric cancer and duodenal ulcer (English)

1 reference

24 August 2017

1

Hideyuki Ubukata

1 reference

24 August 2017

Hiroyuki Nagata

2

1 reference

24 August 2017

Takanobu Tabuchi

3

1 reference

24 August 2017

Satoru Konishi

4

1 reference

24 August 2017

Teruhiko Kasuga

5

1 reference

24 August 2017

Takafumi Tabuchi

6

1 reference

24 August 2017

publication date

20 January 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

14

1 reference

24 August 2017

issue

1

1 reference

24 August 2017

page(s)

4-12

1 reference

Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Helicobacter pylori infection and the development of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

The clinical relevance of strain types of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Meta-analysis of the relationship between cagA seropositivity and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Helicobacter pylori and atrophic gastritis: importance of the cagA status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Oncogenic mechanisms of the Helicobacter pylori CagA protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Duodenal ulcer promoting gene of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

The presence of dupA in Helicobacter pylori is not significantly associated with duodenal ulceration in Belgium, South Africa, China, or North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

homB status of Helicobacter pylori as a novel marker to distinguish gastric cancer from duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Problems associated with the clinical use of proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Proton pump inhibitors and gastric neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Helicobacter pylori eradication for the prevention of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Gastric cancer risk after vagotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Use of cimetidine and other peptic ulcer drugs in Denmark 1977-1990 with analysis of the risk of gastric cancer among cimetidine users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Cimetidine and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Cimetidine is unlikely to increase formation of intragastric N-nitroso-compounds in patients taking a normal diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Treatment of human solid malignancies with autologous activated lymphocytes and cimetidine: a phase II trial of the cancer biotherapy research group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer. British Stomach Cancer Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Incidence of Cancer Among Patients With Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

The effect of NSAIDs and a COX-2 specific inhibitor on Helicobacter pylori-induced PGE2 and HGF in human gastric fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Acid inhibitory medication and risk of gastric and oesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Helicobacter pylori infection and the risk of gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

The future of gastric cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Vegetables, fruit and risk of gastric cancer in Japan: a 10-year follow-up of the JPHC Study Cohort I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Smoking and hyperpepsinogenemia are associated with increased risk for duodenal ulcer in Helicobacter pylori-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Association of serum pepsinogen with atrophic body gastritis in Costa Rica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Involvement of endogenous nitric oxide in the inhibition by endotoxin and interleukin-1 beta of gastric acid secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Nitric oxide mediates the inhibition by interleukin-1 beta of pentagastrin-stimulated rat gastric acid secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Association of the interleukin-1 beta genetic polymorphism and gastric cancer risk in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Interleukin-1beta polymorphisms, Helicobacter pylori infection in individuals from Northern Brazil with gastric adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

IL-1beta and IL-8, matrix metalloproteinase 3, and pepsinogen secretion before and after H. pylori eradication in gastroduodenal phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Gene therapy for gastric ulcers with single local injection of naked DNA encoding VEGF and angiopoietin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Effect of polymorphisms in the 3' untranslated region (3'-UTR) of vascular endothelial growth factor gene on gastric cancer and peptic ulcer diseases in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Host-environment interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Too many rodent carcinogens: mitogenesis increases mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0005-9

Lack of association between pro-inflammatory genotypes of the interleukin-1 (IL-1B -31 C/+ and IL-1RN *2/*2) and gastric cancer/duodenal ulcer in Korean population

21 January 2018

1 reference

12 December 2020

The association of dupA and Helicobacter pylori-related gastroduodenal diseases

1 reference

12 December 2020

Helicobacter pylori-associated ammonia production enhances neutrophil-dependent gastric mucosal cell injury

1 reference

12 December 2020

Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer.

1 reference

12 December 2020

Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma

1 reference

12 December 2020

Proton pump inhibitors may reduce tumour resistance

1 reference

12 December 2020

Relation between Helicobacter pylori cagA status and risk of peptic ulcer disease

1 reference

12 December 2020

Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration

1 reference

12 December 2020

Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation.

1 reference

12 December 2020

Diet and gastric cancer: nutrition survey in a high-risk area

1 reference

12 December 2020

Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis.

1 reference

12 December 2020

Helicobacter pylori dupA gene is not associated with clinical outcomes in the Japanese population

1 reference

12 December 2020

The pathophysiology of peptic ulcer disease

1 reference

12 December 2020

Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study

1 reference

12 December 2020

Products of neutrophil metabolism increase ammonia-induced gastric mucosal damage

1 reference

12 December 2020

Relationship between vascular endothelial growth factor and angiogenesis in spontaneous and indomethacin-delayed healing of acetic acid-induced gastric ulcers in rats

1 reference

12 December 2020

Determinants of Helicobacter pylori pathogenicity.

1 reference

12 December 2020

Prevalence of duodenal ulcer-promoting gene (dupA) of Helicobacter pylori in patients with duodenal ulcer in North Indian population

1 reference

12 December 2020

Multiple genes in the left half of the cag pathogenicity island of Helicobacter pylori are required for tyrosine kinase-dependent transcription of interleukin-8 in gastric epithelial cells

1 reference

12 December 2020

Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features

1 reference

12 December 2020

Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection

1 reference

12 December 2020

Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention

1 reference

12 December 2020

Gastric carcinoma distal to the cardia: a review of the epidemiological pathology of the precusors to a preventable cancer

1 reference

12 December 2020

How does Helicobacter pylori cause duodenal ulcer disease: the bug, the host, or both?

1 reference

12 December 2020

Cimetidine induces apoptosis in gastric cancer cells in vitro and inhibits tumor growth in vivo.

1 reference

12 December 2020

Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan

1 reference

12 December 2020

The coexistence of gastric cancer and duodenal ulcers

1 reference

12 December 2020

Polymorphisms in TNF and HSP-70 show a significant association with gastric cancer and duodenal ulcer.

1 reference

12 December 2020

Aspirin use and risk of fatal cancer

1 reference

12 December 2020

Coexistent duodenal ulcer and gastric malignancy

1 reference

12 December 2020

Perioperative cimetidine administration promotes peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: Results of a randomized controlled clinical trial.

1 reference

12 December 2020

Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori

1 reference

12 December 2020

Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases

1 reference

12 December 2020

Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms

1 reference

12 December 2020

Intestinal metaplasia of gastric mucosa in autopsy materials in Hiroshima and Yamaguchi districts

1 reference

12 December 2020

Detection of early gastric cancer by panendoscopy

1 reference

12 December 2020

Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion

1 reference

12 December 2020

Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan

1 reference

12 December 2020

10.1007/S10120-011-0005-9

Identifiers

DOI

1 reference

24 August 2017

1 reference